SCHEMBL28879347

SCHEMBL28879347

CCCCCCCCCCCCCCC(O)CCC(=O)O.CCCCCc1ccccc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR2 Q9NS75 8/20 0.55
▸ CYSLTR1 Q9Y271 8/20 0.55
▸ FFAR4 Q5NUL3 1/20 0.52
▸ FFAR1 O14842 1/20 0.52
▸ S1PR2 O95136 1/20 0.51
▸ S1PR1 P21453 1/20 0.51
▸ S1PR3 Q99500 1/20 0.51
▸ PTGER1 P34995 1/20 0.47
▸ PTGER4 P35408 1/20 0.47
▸ PTGER3 P43115 1/20 0.47
▸ BID P55957 3/20 0.45
▸ MCL1 Q07820 3/20 0.45
▸ BCL2L1 Q07817 2/20 0.45
▸ BAK1 Q16611 2/20 0.45
▸ KAT8 Q9H7Z6 2/20 0.45
▸ PPARG P37231 1/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ EP300 Q09472 1/20 0.45
▸ KAT2A Q92830 1/20 0.45
▸ KAT2B Q92831 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9456723 0.85 FFAR4 (0.69) CYSLTR2CYSLTR1FFAR4FFAR1S1PR2
SCHEMBL9529521 0.85 FFAR4 (0.69) CYSLTR2CYSLTR1FFAR4FFAR1S1PR2
Aniline SCHEMBL28846696 0.84 FFAR4 (0.61) CYSLTR2CYSLTR1FFAR4FFAR1S1PR2
SCHEMBL9319505 0.80 CYSLTR2 (0.73) CYSLTR2CYSLTR1FFAR4FFAR1S1PR2
SCHEMBL28417932 0.78 MAPT (0.59) CYSLTR2CYSLTR1
SCHEMBL28421388 0.78 MAPT (0.59) CYSLTR2CYSLTR1
SCHEMBL28421444 0.78 MAPT (0.59) CYSLTR2CYSLTR1
SCHEMBL503569 0.78 MAPT (0.59) CYSLTR2CYSLTR1
SCHEMBL28421401 0.78 MAPT (0.59) CYSLTR2CYSLTR1
SCHEMBL28413601 0.78 MAPT (0.59) CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110536620-A Method for manufacturing articles using foam particles NIKE INNOVATE CV 2019-12-03 — — CN disclosed
Send feedback